- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: empagliflozin/linagliptin FDC
Total 4518 results
-
RenJi HospitalTerminatedKidney Transplant; Complications | New Onset Diabetes After TransplantChina
-
AstraZenecaRecruitingHeart Failure and Impaired Kidney FunctionSpain, France, Germany, Italy, United States, Argentina, Czechia, Vietnam, Peru, China, Philippines, Saudi Arabia, Australia, Austria, Canada, Japan, Malaysia, Poland, Taiwan, Thailand, Israel, Brazil, Finland, Greece, Mexico, United Kingdom and more
-
University of VirginiaNational Heart, Lung, and Blood Institute (NHLBI)RecruitingType2 Diabetes | Insulin SensitivityUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Denmark, Canada, Belgium, China, Italy, Germany, Spain, Netherlands, Hungary, Japan, Norway, Poland, Sweden, Czechia
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Institute for Clinical Effectiveness, JapanCompletedCoronary Disease | Diabetes Mellitus | Dipeptidyl-Peptidase 4 Inhibitors | LDL Cholesterol | Glycosylated HemoglobinJapan
-
Boehringer IngelheimCompleted
-
Boryung Pharmaceutical Co., LtdCompletedHypertension | DiabetesKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Instituto Nacional de Cardiologia Ignacio ChavezNot yet recruitingSTEMI | No-Reflow Phenomenon
-
Ananda Basu, MDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaboratorsCompletedType 1 DiabetesUnited States
-
AstraZenecaRecruitingLiver CirrhosisDenmark, Spain, Germany, United States, France, Australia, China, Netherlands, Belgium, Switzerland, Austria, United Kingdom, Taiwan, Canada, Czechia
-
Evidem Consultores SLBoehringer Ingelheim; Merck Serono International SA; European CommissionUnknown
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
Rajaie Cardiovascular Medical and Research CenterTehran Heart CenterRecruitingCABG | Post-operative Atrial FibrillationIran, Islamic Republic of
-
Washington D.C. Veterans Affairs Medical CenterBoehringer IngelheimRecruitingChronic Kidney DiseasesUnited States
-
Yale UniversityRecruiting
-
Sadat City UniversityRecruitingUlcerative ColitisEgypt
-
Shahid Beheshti University of Medical SciencesRecruitingKidney Transplant; ComplicationsIran, Islamic Republic of
-
University Hospital, Basel, SwitzerlandCentre Hospitalier Universitaire Vaudois; Luzerner KantonsspitalRecruitingLiver Failure | Hyponatremia | Kidney Failure | SIADHSwitzerland
-
University Hospital Inselspital, BerneCompletedDumping Syndrome | Hypoglycemia, ReactiveSwitzerland
-
China National Center for Cardiovascular DiseasesRecruitingHypertrophic Cardiomyopathy | Heart Failure With Preserved Ejection FractionChina
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of Sao PauloCompletedDiabetes Mellitus, Type 2 | Coronary Heart Disease | Arrythmia, CardiacBrazil
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Vanderbilt University Medical CenterCompletedObesity | Pre-diabetesUnited States
-
Stanford UniversityCompletedLiver Cirrhosis | Cirrhosis | Ascites | Ascites Hepatic | Sodium-Glucose Transporter 2 InhibitorsUnited States
-
Zhijun SunEnrolling by invitationHeart Failure | Heart Failure With Preserved Ejection FractionChina
-
University Hospital, Basel, SwitzerlandCompletedHyponatremia | SIAD - Syndrome of Inappropriate AntidiuresisSwitzerland
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Genuine Research Center, EgyptEva PharmaCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Italy, Poland, Russian Federation, Spain, Greece, Serbia, Thailand, Brazil, Hungary, Argentina
-
Amsterdam UMC, location VUmcCompleted
-
Ain Shams UniversityNot yet recruiting
-
Alexandria UniversityRecruitingHeart Failure With Reduced Ejection FractionEgypt
-
Maria Sklodowska-Curie National Research Institute...Medical Research Agency, PolandRecruiting
-
National Institute of Cardiology, Warsaw, PolandAmsterdam UMC, location VUmc; University of Eastern Finland; Medical University...RecruitingHeart Failure | Hypertrophic CardiomyopathyPoland
-
NHS Greater Glasgow and ClydeUniversity of GlasgowActive, not recruitingMyocardial InfarctionUnited Kingdom
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruiting
-
Centre Hospitalier Universitaire VaudoisCompleted
-
Aristotle University Of ThessalonikiUnknownHypertension | Type II DiabetesGreece
-
Boehringer IngelheimCompleted
-
Juntendo UniversityBoehringer IngelheimRecruiting
-
Jacob MollerRigshospitalet, Denmark; University Hospital Bispebjerg and Frederiksberg; Hillerod... and other collaboratorsRecruitingHeart Failure | ObesityDenmark
-
University Hospital Inselspital, BerneBoehringer Ingelheim; University of BernCompleted
-
Ain Shams UniversityCompletedPharmacokinetics | PharmacogenomicEgypt